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A systematic review to examine the relationship between objective and
patient-reported outcome measures in sinonasal disorders
recommendations for use in research and clinical practice
Ngan Hong Ta, MBBS1 , Jack Gao, MBBS2 and Carl Philpott, FRCS(ORL-HNS)3
Background Common sinonasal disorders include chronic
rhinosinusitis CRS allergic rhinitis AR and a deviated
nasal septum DNS which oen coexist with shared
common symptoms including nasal obstruction olfac-
tory dysfunction and rhinorrhea Various objective out-
come measures and patient-reported outcome measures
PROMs are used to assess disease severity however
there is limited evidence in the literature on the cor-
relation between them This systematic review aims to
examine the relationship between them and provide
recommendations
Methods A search of MEDLINE and EMBASE identified
studies quantifying correlations between objective out-
come measures and PROMs for the sinonasal conditions
using a narrative synthesis
Results In total 	 studies met inclusion criteria For
nasal obstruction rhinomanometry shows a lack of corre-
lation whereas peak nasal inspiratory flow PNIF shows
the strongest correlation with PROMs r > 
 The Snif-
fin’ Stick test shows a stronger correlation with PROMs r
> 
 than the University of Pennsylvania Smell Identifica-
tion Test UPSIT r < 
 Computed tomography CT si-
nus scores show little evidence of correlation with PROMs
and nasal endoscopic ratings weak correlation r < 

Conclusion Overall objective outcome measures and
PROMs assessing sinonasal symptoms are poorly corre-
lated and we recommend that objective outcome mea-
sures be used with validated PROMs depending on the set-
ting PNIF should be used in routine clinical practice for
nasal obstruction rhinomanometry and acoustic rhinome-
try may be useful in research The Sniffin’ Sticks test is rec-
ommended for olfactory dysfunction with UPSIT as an al-
ternative CT scores should be excluded as a routine CRS
outcome measure and endoscopic scores should be used
in combination with PROMs until further research is con-
ducted © 2020 The Authors. International Forum of Allergy
& Rhinology published by Wiley Periodicals LLC on behalf of
American Academy of Otolaryngic Allergy and American Rhi-
nologic Society.
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S inonasal disorders are common conditions with the po-tential to cause a significant impact to the quality of life
(QoL) of sufferers.1,2 The most prevalent of these include
chronic rhinosinusitis (CRS), allergic rhinitis (AR), and a
deviated nasal septum (DNS). These 3 conditions share
some common symptoms (nasal obstruction, discharge, fa-
cial pain/pressure, hyposmia/anosmia) that may be assessed
by various patient-reported outcome measures (PROMs)
and objective outcome measures.
PROMs are disease-specific symptom scores used to mea-
sure QoL complaints and, because the goal of treatment
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typically aims to improve patient QoL, they are used
to assess disease severity and guide management plans.
Common PROMs include the following: Rhinosinusitis
Outcome Measurement (RSOM); Chronic Sinusitis Survey
(CSS); Questionnaire of Olfactory Disorders (QOD); Si-
nusitis Control Test; Nasal Obstruction and Septoplasty
Effectiveness Scale (NOSE); visual analogue scale (VAS) of
specific symptoms, such as smell and nasal obstruction, or
for global symptoms; and the 22-item Sino-Nasal Outcome
Test (SNOT-22).
Objective outcome measures are tests performed to as-
sess physiological parameters and response to treatment,
independently of patient response. The commonly used
tests assess nasal endoscopy, computed tomography (CT)
scans, and physiological measurements. For example, nasal
endoscopy interpretation can be standardized to allow
for comparison between studies by scores including the
Lund-Kennedy Score (LKS),3 Lildholdt,4 Kupferberg,5 and
Philpott-Javer scores.6 CT scans are often staged using the
Lund-Mackay score (LMS).7 Nasal physiological measure-
ments include peak nasal inspiratory flow (PNIF), acous-
tic rhinometry (AcR), rhinomanometry, rhinostereometry,
and the measurement of mucociliary clearance (MCC) us-
ing rhinoscintigraphy and the saccharin test. Olfaction is
most assessed using the Sniffin’ Sticks test and the Univer-
sity of Pennsylvania Smell Identification Test (UPSIT), al-
though other test kits are available.
The European position paper on rhinosinusitis and nasal
polyps 2012 and 2020 (EPOS 2012 and EPOPS 2020) both
emphasize the lack of literature investigating the correlation
between patient-reported and objective outcome measures
for CRS.8,9 Elsewhere, it is noted that the relationship be-
tween subjective and objective assessments of nasal patency
has also remained highly controversial.10–12 Another review
highlights that, despite the existence of numerous measure-
ment tools for assessing nasal patency in DNS, no “gold
standard” objective tools are in routine widespread use.13
Overall, the lack of depth in the evidence for the associ-
ation between objective outcome measures and PROMs in
the sinonasal disorders (CRS, AR,DNS) highlights the need
to better evaluate the relationship between them.
Aims And Objectives
This systematic review aims to examine the correlation be-
tween objective outcome measures and disease severity (as
characterized by PROMs) in sinonasal disorders and make
recommendations for both research and clinical settings.
Identifying suitable tools for rhinologists will help to se-
lect the appropriate investigations to improve clinical as-
sessment and research efficiency.
Methodology
A literature search was undertaken using the Preferred Re-
porting Items for Systematic Reviews and Meta-Analyses
(PRISMA) checklist14 with search terms including and re-
lating to “sinonasal disorders,” “objective outcome mea-
sures,” “patient rated outcome measures,” and “correla-
tion.” The specific search terms for the commonly used
outcome measures were obtained from an Otolaryngol-
ogy book chapter.7 All search terms used can be found
in Appendix A. Synonyms and related terms within these
fields were connected with the Boolean operator “OR.”
These 3 search domains were then combined with the
Boolean operator “AND.”The titles and abstracts of papers
were screened. Both Medline (OVID) and EMBASE were
searched for medical literature. An example of the search
strategy for Medline (OVID) can be found in Appendix A.
Eligibility criteria
Inclusion criteria
Studies quantifying the correlation between objective out-
come measures and PROMs in the sinonasal disorders.
Exclusion criteria
• Studies with either objective outcome measures or
PROMs alone, but not both.
• Studies with mixed populations of the sinonasal disor-
ders; eg, AR and CRS, etc.
• Studies where systemic disorders were the underlying
cause of sinonasal disease; eg, cystic fibrosis, granulo-
matosis with polyangiitis, etc.
• Non peer-reviewed publications.
• Non-English publications.
Study selection and data extraction
Three reviewers were involved in the review. Two inde-
pendent reviewers conducted the selection of studies and
extracting data. All disagreements between the reviewers
were discussed with the senior reviewer to reach a consen-
sus. All data were managed using EndNote x72.1 (Clari-
vate, Philadelphia, PA). AMicrosoft Excel spreadsheet (Mi-
crosoft Corp., Redmond, WA) was used to extract relevant
data from the included studies. Fields included authors, year
of publication, aim, number of participants, sinonasal dis-
order, PROMs, and objective outcome measures utilized.
Critical assessment of the included studies
To assess the quality of the included studies, a bespoke tool
(Table 1) was devised fromThe Joanna Briggs Institute Crit-
ical Appraisal tools for cross-sectional studies15 and the
NICE Quality appraisal checklist – quantitative studies re-
porting correlations and associations.16 An overall percent-




The databases were all searched on April 30, 2020, re-
vealing 433 publications (after removal of duplicates).
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FIGURE 1. PRISMA flowchart. PRISMA = Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses.
Abstracts were reviewed and any irrelevant publications
were removed, leaving 70 papers to be read as full texts.
A total of 59 studies were included in the narrative synthe-
sis (see PRISMA chart, Fig. 1 for details).
Methodological critical appraisal of the included
studies
Overall, the average critical appraisal score of the 59 in-
cluded studies is 88% (standard deviation [SD] 6.78%),
with only 1 study obtaining a perfect score.17 All included
studies are observational studies with intrinsic limitations
including bias and confounding that could distort correla-
tion findings.
Almost all studies used nationally or internationally ac-
cepted criteria to diagnose the sinonasal disorders. In to-
tal, 97% of the included studies precisely outlined their
inclusion and exclusion criteria, with the exception of 2
studies.18,19 After assessing these 2 studies in full-text, it
was decided to include them because they met the inclu-
sion criteria and their statistical analyses provided useful
information for our review.
Defining the correlation between objective outcome mea-
sures and PROMs was the main objective of 78% of the in-
cluded studies. A total of 13 studies20–32 coincidentally pro-
vided information about the correlation between PROMs
and objective outcome measures as a part of their ex-
ploratory statistical analyses.
The most common deficiency of the included papers
was the use of non-validated outcome measures. One
third of the included studies19,20,26,28–30,32–45 failed to
use validated outcome measures. All included studies
used appropriate statistical tests for quantifying corre-
lations including bivariate correlation tests and regres-
sion analysis. A total of 15 studies were statistically
underpowered23,28,31,33,35,38,39,41,43,45–50 to detect a correla-
tion because their sample sizes were less than 50 according
to our medical statistician’s advice.
Results synthesis
Meta-analysis was considered inappropriate due to the het-
erogeneity of the outcome measures utilized in the included
studies, determined by Cochran’s Q test. Therefore, the
Cochrane Consumers and Communication Review Group
guidance on data synthesis and analysis was consulted for
the narrative synthesis process of our review.51 Table 2 il-
lustrates a summary of correlation status and strength be-
tween different pairs of outcome measures according to 4
main sinonasal symptom groups: nasal obstruction, olfac-
tory dysfunction, global CRS symptoms, and MCC dys-
function symptoms/rhinorrhea.
PROMs
For nasal obstruction, the most commonly studied PROM
was the visual analogue scale (VAS) for nasal ob-
struction which was used in 45% of the included
studies.17,36,40,41,44,48–50,52–60 Only 25% of the included pa-
pers used the validated NOSE questionnaire for nasal
obstruction.30,31,35,46,48,50,61,62 Because the NOSE question-
naire was only validated as a PROM for nasal obstruction
due to a deviated septum for patients undergoing septo-
plasty in 2004,63 studies conducted prior to 2004 would
not have been able to use the questionnaire. Nevertheless, a
large number of studies conducted after 2004 opted not to
utilize the NOSE questionnaire.17,19,29,35,40–42,44,48,50,53–60
For olfactory dysfunction, the 2 most popular choices of
PROMs used were the SNOT-2217,39,40,64 and a VAS for the
sense of smell17,40,64,65; only 3 studies utilized the Question-
naire of Olfactory Disorders (QOD).37,39,66
The SNOT-2267 was used in 83% of the included
papers,20,21,23,24,26,34,40,45,60,68–73 with VAS used in 10 out
of 18 papers,20,26,40,59,60,65,71,72,74 and SNOT-22 was used
to correlate with rhinoscintigraphy results.33,34
Objective outcome measures/tools
Nasal obstruction tools. There were 36 included
studies evaluating the correlation for nasal obstruc-
tion in CRS, AR, and DNS, covering 3 main ob-
jective measures: rhinomanometry,19,30,31,35,48,49,52–55,57,61
AcR,19,28,29,35,36,46,54,56,58 and PNIF17,42,44,50,58,62 (12, 9,
and 8 studies, respectively). A small number of publications
(19%) utilized various uncommon and non-validated mea-
sures for nasal obstruction.17,36,40–43,46,58
Rhinomanometry
Rhinomanometry is a well-established and standardized
quantitative tool to objectively assess nasal obstruc-
tion.75,76 It measures nasal airway resistance, which is cal-
culated from air flow and pressure readings taken from the
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nasal cavity. It has been considered the gold standard by
some researchers,77 but is an expensive and time-consuming
test, often reserved for research. Statistically significant
correlations between rhinomanometry and PROMs were
found in all included studies in all of the included sinonasal
disorders; however, the majority of the included publica-
tions showed a weak correlation (r < 0.5) and 14% of
the included papers reported a moderate correlation (r >
0.5).30,49,53,54,61 The strongest correlation was identified in
only 1 paper with AR patients (r> 0.7).53 There was amod-
eration correlation shown in 2 studies with DNS patients
(r > 0.5).30,78 The relationship between rhinomanometry
and PROMs is not well-studied in CRS patients, with only
1 study demonstrating a very weak and clinically insignifi-
cant correlation.49
AcR
AcR is an alternative tool to assess nasal obstruction. It
measures the geometry of the nose by the means of acous-
tic reflection.79 It estimates the volume of the nasal cav-
ity through quantifying the cross-sectional area of the nose.
This test relies on the reflection of an audible sound wave
(150 to 10,000 Hz) which is propagated from a click in a
tube under the nostril.80 Although AcR provides useful in-
formation, it is largely a research tool due to the complex-
ity of performing the test in routine clinical practice. Out of
the 9 studies quantifying the correlation between AcR and
PROMs, the majority showed no correlation,19,28,35,46,54
whereas the studies demonstrating significant correlation
only revealed a variable strength of correlation.29,36,56,58 In
AR patients, there was a weak to moderate correlation be-
tween AcR and PROMs.29,36,56 A stronger correlation be-
tween AcR and PROMs (r = 0.5) was demonstrated in 1
study with CRS patients.58
PNIF
PNIF is another tool to assess nasal obstruction
objectively.81 A peak nasal inspiratory flowmeter in-
cludes a mouthpiece placed over the nose and the mouth
to measure nasal flow with the mouth closed. When using
the device, subjects are asked to inhale sharply through the
nose 3 times and the best of 3 readings is taken as the final
result.82 It has been considered to be the simplest, reliable,
reproducible, and most widely available objective tool in
measuring nasal patency.81,83
There were only 8 included studies evaluating the cor-
relation between PNIF and PROMs, suggesting more re-
search is needed in evaluating this inexpensive, easily ap-
plied, fast, and portable tool. A total 5 out of 8 studies
identified a correlation between PNIF and PROMs in AR
and CRS. The strength of correlation was weak in the ma-
jority of the included papers (0.35 < r < 0.5)17,42,44,59,60;
however, stronger correlation was noted in CRS patients (r
> 0.5).17,50,58 The only publication in the DNS population
found no statistically significant correlation between PNIF
and PROMs, post-septorhinoplasty.62
Olfactory dysfunction tools. Although olfactory dys-
function can exist in all of the considered sinonasal dis-
orders, all 11 included studies were conducted exclusively
within the CRS population. The most commonly utilized
objective outcome measures used to assess olfactory dys-
function were the Sniffin’ Sticks test and the UPSIT. The rest
of the included papers were considered uncommon, non-
validated tools for assessing olfaction.38–40,47
Sniffin’ Sticks test
The Sniffin’ Sticks test assesses 3 components of olfac-
tion including threshold (T), discrimination (D) and iden-
tification (I) testing to give a composite TDI score.84
The correlation between TDI scores and PROMs was
considered strong (r > 0.7) in the all of the included
publications.17,37,65,85 The strongest correlation was found
with the QOD,37 especially in patients with severe CRS
with nasal polyps (CRSwNP) with an LMS of >15 and in
allergic fungal rhinosinusitis (AFRS).65,85
UPSIT
The UPSIT is another common smell test that has also
been validated for use in different parts of the world,86–88
but only tests olfactory identification. Three papers eval-
uated its relationship with PROMs,64,66,89 2 of which
demonstrated a weak correlation.64,66 The largest sized
study with 367 patients showed no statistically significant
correlation.89
Clinical staging tools for CRS. The most studied ob-
jective outcome measure for CRS clinical findings was the
LMS in 18 out of 23 publications.18,21–26,34,40,45,68–72,74 LKS
was the next most commonly utilized tool with 5 out of 23
studies.18,20,40,65,70 Themajority of the included papers con-
sidered both main phenotypes of CRS with the exception of
1 paper studying AFRS.65
LMS
The LMS90 is based on points (0 = normal, 1 = par-
tial opacification, 2 = total opacification) given for the
degree of opacification of the various sinus groups; with
the ostiomeatal complex scored as 0 or 2. The ma-
jority of the included publications (75%) demonstrated
a lack of correlation with PROMs. Very weak corre-
lations (r < 0.35) were found in the remaining 25%
publications.18,21–26,34,40,45,68–72,74,91,92 Of note, the largest-
scale study with 1840 CRS patients showed a clinically in-
significant correlation (r = 0.058).93
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LKS
In 1995, the LKS was designed as an endoscopic staging
system to describe endoscopic findings in CRS patients who
have already undergone endoscopic sinus surgery (ESS). It
is based on the degree of scarring, crusting, edema, polyps,
and discharge.3 The system scores for the following signs:
scarring (0 = absent; 1 = mild; 2 = severe), crusting (0
= absent; 1 = mild; 2 = severe), edema (0 = absent; 1 =
mild; 2 = severe), polyps (0 = none; 1 = middle meatus;
2 = beyond middle meatus), and discharge (0 = none; 1 =
clear and thin; 2 = thick and purulent). Overall, LKS cor-
related poorly with PROMs for global CRS symptoms in
the included studies. Although statistically significant cor-
relations were found between LKS and the VAS of CRS
symptoms, they were shown to be weak (r < 0.35).20,40
Only 1 paper demonstrated a slightly stronger correlation
(r = −0.51) where the VAS was correlated with a modi-
fied Kupferberg endoscopic staging score (Philpott-Javer),6
which was modified for AFRS.65 No statistically significant
correlation was found between LKS and the CSS, Rhinosi-
nusitis Disability Index,18 or the SNOT-22.20,40,70
MCC dysfunction tools. MCC is a key first-line defense
mechanism in the upper and lower respiratory tract and has
shown to be significantly decreased in CRS patients,94–97
suggesting that defective MCC may have a role in the
pathogenesis of CRS8 and AR.98 Rhinorrhea may be con-
sidered the closest sinonasal symptom to correlate with
MCC dysfunction in CRS and AR.8,99
Rhinoscintigraphy is an imaging test to assess nasalMCC
in CRS patients with the use of technetium-99m macro-
aggregated albumin. The only 2 included studies quantified
the relationship between rhinoscintigraphy and SNOT-22
in CRS populations; however, neither of these publications
showed a statistically significant correlation.34,100 No study
was performed in AR patients. The saccharin test is an al-
ternative, simpler, reliable, and cheaper option to measure
MCC.101 A normal result (less than 35 minutes) is useful
in excluding early MCC dysfunction.8 No included publi-
cations quantified the correlation between MCC measured
by the saccharin test and PROMs for rhinorrhea. Overall,
there is a paucity of literature concerning the relationship
between objective measures of MCC and PROMs.
Discussion
Summary of the key findings
The key findings of the correlation between the outcome
measures are outlined in Table 2.
Strengths
This systematic review with recommendations provides the
first comprehensive overview of the literature on the cor-
relation between objective outcome measures and PROMs
for the main sinonasal disorders (CRS, DNS, AR) to date.
This systematic review incorporates a methodological criti-
cal appraisal of the included studies using a bespoke check-
list developed from 2 validated checklists.15,16 Because the
systematic review was conducted by 3 reviewers, this min-
imized any potential errors and selection bias commonly
occurring in systematic reviews conducted by 1 reviewer.
Limitations
Although a systematic approach was conducted during our
literature search, publication bias is always present. Limita-
tions on resource availability meant that only English lan-
guage publications were included in the review.Where pos-
sible, included studies were checked to ensure adherence
to the diagnostic criteria for the sinonasal disorders (CRS,
DNS, AR) present at the time of the studies. An inevitable
limitation of this review is that older criteria utilized in
some of the included papers might have not conformed to
current diagnostic criteria. There were a limited number of
studies identified for review in the case of objective out-
come measures that have been poorly studied. Only Med-
line OVID and Embase OVID databases were searched for
high-quality peer-reviewed studies and, consequently, other
studies in the gray literature102 will have been overlooked.
The included papers were analyzed using a narrative ap-
proach instead of conducting a meta-analysis, precluding
the assessment of publication bias. Although a bespoke crit-
ical appraisal tool was generated from 2 other well-known
checklists to accommodate the included studies, it is a self-
designed and non-validated tool.
Implications for future research
Our recommendations for the use of the objective
outcome measures
With a focus on patient-centered care, outcome measures
should not only be able to detect the difference between
the effect of study interventions but also reflect aspects
of the disease felt to be important to participants in the
study.103,104 Therefore, one could argue that objective out-
comemeasures are not always helpful due to the lack of cor-
relation with PROMs which are crucial to inform improve-
ments in health care delivery. On the other hand, it is well
known in other medical specialties that objective outcome
measures and PROMs often do not correlate.105,106 This
discrepancy can be explained by considering that PROM
results are multifactorial whereas objective outcome mea-
sures only measure biological/physiological aspects of the
puzzle. Thus, researchers can dispute that although cer-
tain objective outcome measures may not correlate with
PROMs, the objective outcome measures can be useful if
they provide different information and are appropriate to
conduct in their study.
We aim to make recommendations for the use of the
objective outcome measures in both routine clinical prac-
tice and in research settings. This section outlines our
recommendations for the objective tools used to assess
nasal obstruction, olfactory dysfunction, global CRS symp-
toms, and MCC dysfunction. A full consideration of the
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correlation findings from our review and other factors in-
cluding time, costs, complexity, and efficiency has been




Most of the included papers reported a correlation be-
tween PNIF readings and PROMs, which may suggest re-
dundancy in performing the investigation.However, all cor-
relations found were considered weak to moderate, and
PNIF is a simple, easy and cheap test to perform,81 being
the most widely utilized tool for assessing nasal patency in
ear, nose, and throat (ENT) clinics. Additionally, it has been
demonstrated to be as valid and reliable as the “gold stan-
dard” measures for assessing nasal patency including rhi-
nomanometry and AcR.83 Overall, we recommend PNIF be
used in routine clinical practice as an objective tool in con-
junction with a validated PROM to assess changes in nasal
patency in the main sinonasal disorders. We also support
the use of PNIF in research settings due to its low cost and
simplicity to reduce patient burden and improve research
efficiency. More work is needed to confirm that PNIF is a
useful objective tool for structural nasal obstruction such
as DNS, so we make a more reserved recommendation of
PNIF to be used alone as an objective tool for DNS, but
always in conjunction with a validated PROM.
Rhinomanometry
Most of the included papers showed a weak correlation be-
tween rhinomanometry and a self-rating score of nasal ob-
struction. Although rhinomanometry provides “gold stan-
dard” objective measurements of nasal patency,76 it has
only been generally performed in research settings due to
the time, financial constraints, and the scarcity of the tool in
routine ENT clinics. Additionally, undergoing this lengthy
test can be inconvenient for most people, especially if re-
peated over time as an outcome measure in research or
routine clinical practice.We recommend that the use of rhi-
nomanometry should be limited to research scenarios only
and that in routine clinical practice it is replaced by the
use of a more cost- and time-effective investigation, such
as PNIF.
AcR
Most of the included publications showed no statistically
significant correlation between AcR and the SNOT-22
questionnaire. AcR is a complicated tool to perform requir-
ing the users to be trained to obtain meaningful readings
and it is often unavailable in ENT clinics.7 Therefore, we
recommend that AcR should remain a research tool and,
even in research settings, we propose that PNIF may rep-
resent a better alternative to AcR to reduce the burden of
many investigations on patients and researchers.
Other tools
There is insufficient high-quality evidence, in terms of the
number of studies and the quality of the publications, to
make any recommendations for the use of the various
non-validated tools for assessing nasal obstruction, such as
rhinostereometry. More research should be conducted to




A strong correlation between the Sniffin’ Sticks TDI scores
and PROMs was noted in the majority of included stud-
ies, suggesting that the use of PROMs alone to assess ol-
faction is sufficient. However, a position paper on olfac-
tory dysfunction has reported that self-rating for the sense
of smell is often unreliable and subjective olfactory assess-
ment should not be undertaken in isolation, given its poor
accuracy.107 In addition to being the most validated olfac-
tory test globally, it has been used extensively in research
and is more cost-effective than single-use smell tests, as the
Sniffin’ Sticks can be reused numerous times during their
shelf life (12 to 18 months).
We recommend the Sniffin’ Sticks test in research settings,
as it provides amore comprehensive assessment of olfaction
compared to UPSIT. On the contrary, the UPSIT has the
advantage that it can be sent by post to patients for test-
ing at home and does not require someone to administer
the test. We advise researchers to consider the availability
of testing resources and the research personnel required to
perform the Sniffin’ Sticks tests at multiple follow-ups, bal-
anced against the overall cost of the kits, compared to the
UPSIT.
In routine clinical practice, we recommend the Sniffin’
Sticks test in conjunction with a validated PROM for all
patients presenting with olfactory dysfunction at the first
clinical visit, thereby establishing a baseline assessment. The
decision to employ the smell test in routine clinical follow-
up should depend on local factors such as cost, time, and
the availability of clinical staff.
UPSIT
The correlation between the UPSIT and PROMs ranges
from no statistically significant correlation to a weak cor-
relation in all the included studies. Although UPSIT is a
reliable, well-validated, standardized smell test, the major
drawback is that it assesses odor identification alone, which
may explain the above issue with varying correlations. Be-
cause UPSIT is a single-use test, it may be more costly (ap-
proximately £15 per kit) if used in a study with large patient
numbers; however, it requires no clinician supervision and
poses negligible burden on patients. For research settings,
we would recommend this as a second-choice test with the
caveat of it being advantageous where participants are un-
able to travel to the study sites. In routine clinical practice,
the UPSIT can be the first choice for a simple and quick
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TABLE 4. A summary of the recommendations for the use of PROMs for each sinonasal disorder
Diagnosis Recommended validated PROMs to
be used






CRS = chronic rhinosinusitis; NOSE = nasal obstruction and septoplasty effectiveness scale; PROM = patient-reported outcome measure; QOD = questionnaire of
olfactory disorders; RQLQ = Rhinoconjunctivitis Quality of Life Questionnaire; SNOT-22 = 22-item Sino-Nasal Outcome Test.
smell test with a validated PROM in non-universal health
care systems where patients purchase their own tests.
Clinical staging tools for CRS symptoms
LMS
LMS has become a popular staging score for CT scans in
CRS due to its simplicity, clarity, and its amenability for use
by non-specialist radiologists. Because the relationship be-
tween measurable effects of biological variables and symp-
toms is complex, the absence of the correlation between
LMS and PROMs found in the majority of the included
studies is unsurprising. LMS was never expected to cor-
relate with symptom severity, merely created to evaluate
quantitatively the burden of inflammation in CRS.90 Al-
though a CT scan may be required as a diagnostic test for
CRS (where endoscopy findings are inconclusive)8 and is
mandatory for all patients undergoing any form of sinus
surgery, LMS is not ideally placed as an outcome measure
to be repeated over time in all scenarios, especially given the
radiation exposure. This latter concern may change with
the improved availability of cone beam CT scanning. Over-
all, we recommend that LMS should only be used as a clin-
ical staging tool for CRS at the current time.
LKS
LKS remains the most widely used endoscopic scoring sys-
tem in rhinological research and was created as a stan-
dardized objective outcome measure by providing a nu-
meric score summarizing nasal endoscopic appearances,
and also aiding assessment after ESS.3 LKS was found to
not correlate with the SNOT-2220,40,70 and poorly corre-
lated with other non-validated PROMs including the VAS
of CRS symptoms.20,40 This suggests that LKS provides dif-
ferent information on the CRS disease extent and we rec-
ommend that it should always be performed with a val-
idated PROM for CRS (eg, SNOT-22) in both research
and routine clinical practice settings. Our suggestion is sup-
ported by the Chronic Rhinosinusitis Outcome Measures
(CHROME) paper’s findings,108 stating that the 15 most
highly rated outcomes in the study could be measured by
the SNOT-22 repeated over time, in conjunction with LKS.
The standardization of endoscopic appearances provided
by LKS helps to reduce the heterogeneity of outcome mea-
sures in studies and hence facilitate systematic reviews and
meta-analyses. Hence, we recommend LKS as an objective
outcome measure at all visits throughout studies, to com-
pare their results with other studies. For routine clinical
practice, the documentation of LKS depends on the clini-
cian’s preference. A set of LKS obtained pre-ESS and post-
ESS or a record of repeated LKS over time could be useful
in a personal audit of the ENT surgeon’s own practice.
MCC dysfunction symptoms/rhinorrhea tools
Although rhinoscintigraphy has been demonstrated to be
reliable in detecting a deduction in MCC,97 it is poorly cor-
related to self-rated symptomatic scores in our review. Due
to the little evidence available, we were unable to make any
recommendations for the use of any objective tools assess-
ing MCC dysfunction.
Our recommendations for PROMS
Table 4 provides a summary of the recommendations for
the use of PROMs for each sinonasal disorder. PROMs
should be validated for a specific sinonasal disorder with
a specific patient population due to cultural influences on
their suitability. For CRS, a systematic review109 found that
the highest-quality validated PROM is the SNOT-22. For
nasal obstruction caused by DNS, the NOSE questionnaire
is only currently validated PROM.63 For olfactory dysfunc-
tion, the QOD has been validated37 in CRS. For AR, the
Rhinoconjunctivitis Quality of Life Questionnaire (RQLQ)
is a widely validated PROM for AR worldwide110 and is
more disease-specific.
Although the VAS of different sinonasal symptoms has
been used extensively in the included papers and advocated
by EPOS 2020 for measuring symptom control due to its
simplicity and availability, it is a general and non-validated
PROM for specific sinonasal disorders. Overall, we recom-
mend the use of the validated PROMS for sinonasal disor-
ders including the SNOT-22 questionnaire, the NOSE ques-
tionnaire, and the RQLQ. If it is not feasible to use a vali-
dated PROM, a recognized quantitative scale such as a VAS
of symptoms should be used as a substitution for measuring
symptom control.
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Recommendations for future research
Further research is required to facilitate the selection of
the most suitable objective outcome measures in rhinology
to minimize redundancy and reduce patient and research
burden. Specifically, more emphasis should be paid to the
poorly studied objective tools such as PNIF, the Sniffin’
Sticks test, and the UPSIT to strengthen recommendations
for their use in the sinonasal disorders.
Further research should aim to produce an international
guideline on “gold standard” objective outcome measures
for the sinonasal disorders.
Conclusion
There is limited literature on the correlation between objec-
tive outcome measures and PROMs in the sinonasal disor-
ders. Overall, we recommend that the setting-appropriate
objective outcome measures are used with validated
PROMs for sinonasal symptoms. More work on the rela-
tionship between the outcome measures in sinonasal disor-
ders is needed to confirm our recommendations.
APPENDIX A: OVID MEDLINE SEARCH




5 Peak inspiratory nasal flow.mp. (10)
6 PNIF.mp. (222)
7 Peak Expiratory Flow.mp. (9549)
8 PEF.mp. (4948)
9 Mucociliary Clearance/ (2515)
10 saccharine test.mp. (56)
11 Sniffin Sticks test.mp. (280)
12 smell test*.mp. (279)
13 Olfactory test*.mp. (848)
14 Sniffin Sticks.mp. (708)
15 University of Pennsylvania Smell Identification Test.mp. (429)
16 UPSIT.mp. (350)
17 Tomography, X-Ray Computed/ (380121)
18 CT sinus.mp. (25)
19 Lund Mackay scores.mp. (124)
20 Lund Kennedy scores.mp. (43)
21 Nasal Endoscopy.mp. (1641)
22 Endoscopic score.mp. (551)
23 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 (33194)
24 9 or 10 (2538)
25 11 or 12 or 13 or 14 or 15 or 16 (1880)
26 17 or 18 or 19 (380209)
27 20 or 21 or 22 (2213)
28 Sino-nasal Outcome Test-22.mp. (127)
29 SNOT-22.mp. (634)
30 SNOT 22.mp. (634)
31 (SNOT-16 or SNOT 16).mp. (15)
32 (SNOT-20 or SNOT 20).mp. (277)
33 (SNOT-23 or SNOT 23).mp. (4)
34 (31-Item Rhinosinusitis Outcome Measurement or RSOM-31).mp. (20)
35 Questionnaire of Olfactory Disorders.mp. (25)
36 Sinusitis Control Test.mp. (1)
37 (EuroQoL five-dimensional questionnaire or EQ-5D).mp. (8343)
38 Chronic Sinusitis Survey.mp. (78)
39 (Nasal Obstruction and Septoplasty Effectiveness Scale).mp. (4)
40 NOSE score.mp. (138)
41 (visual analogue scale or visual analog scale).mp. (51284)
42 28 or 29 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 38 (9371)
43 39 or 40 (140)
44 23 and 42 (51)
45 23 and 43 (22)
46 23 and 41 (354)
47 25 and 42 (53)
48 25 and 41 (78)
49 24 and 42 (19)
50 27 and 42 (113)
51 27 and 43 (7)
52 27 and 41 (118)
53 26 and 42 (144)
54 26 and 43 (2)
55 26 and 41 (849)
56 44 or 45 or 46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 (1626)
57 nose diseases/ or nasal obstruction/ or nose deformities, acquired/ or
paranasal sinus diseases/ or rhinitis/ (30128)
58 septal deviation.mp. (986)
59 rhinosinusitis.mp. (9313)
60 57 or 58 or 59 (34664)
61 56 and 60 (465)
62 limit 61 to English language (433)
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